Tag: pill

Since 2022, Star Equity Fund repeatedly called on Servotronics to explore strategic alternatives

The 2025 update explores how evolving consumer interest in brain fog, coffee-enhanced wellness routines, and ingredient transparency is shaping the future of cognitive support.

Higher dose of Wegovy^® provided average weight loss of 21% in people with obesity – with a third achieving 25% or more – according to data presented at ADA

Chicago, Illinois, June 16, 2025 (GLOBE NEWSWIRE) -- Black Girl Vitamins (BGV), a brand deeply committed to the health and empowerment of the Black community, announced its comprehensive "Nourishing Our Roots" campaign in honor of Juneteenth. This powerful theme encourages Black women to reflect on the deep historical roots of their heritage, which are increasingly at risk of erasure, and to prioritize the roots of their wellness, essential for maintaining health in a world that often fails to prioritize them. 

SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today held its Annual Meeting of Stockholders (the “Annual Meeting”) in a virtual-only format. Preliminary results from the Annual Meeting indicate that two proposals were approved and two proposals were rejected by Vaxart stockholders.